The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Inverse, protean, and ligand‐selective agonism: matters of receptor conformation
Abstract
Concepts regarding the mechanisms by which drugs activate receptors to produce physiological response have progressed beyond considering the re¬ceptor as a simple on‐off switch. Current evidence suggests that the idea that agonists produce only vary¬ing degrees of receptor activation is obsolete and must be reconciled with data to show that agonist efficacy has texture as well as magnitude. Thus, agonists can block system constitutive response (inverse agonists), behave as positive and inverse agonists on the same receptor (protean agonists), and differ in the stimulus pattern they produce in physiological systems (ligand‐selective agonists). The molecular mechanism for this seemingly diverse array of activities is the same, namely, the selective microaffinity of ligands for different conformational states of the receptor. This paper reviews evidence for the existence of the various types of agonism and the potential therapeutic utility of differ¬ent agonist types.—Kenakin, T. Inverse, protean, and ligand‐selective agonism: matters of receptor confor¬mation. FASEB J. 15, 598‐611 (2001)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Energy Landscapes and Motions of Proteins
Frauenfelder, H., Sligar, S. G., & Wolynes, P. G. (1991) · Science · doi:10.1126/science.1749933 · Cited by 3,250
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134
MODEL SYSTEMS FOR THE STUDY OF SEVEN-TRANSMEMBRANE-SEGMENT RECEPTORS
Dohlman, H. G., Thorner, J., Caron, M. G., & Lefkowitz, R. J. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.60.070191.003253 · Cited by 1,379
Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer
Cuttitta, F., Carney, D. N., Mulshine, J., Moody, T. W., Fedorko, J., Fischler, A., & Minna, J. D. (1985) · Nature · doi:10.1038/316823a0 · Cited by 1,349
Samama, P., Cotecchia, S., Costa, T., & Lefkowitz, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53442-6 · Cited by 1,257
GABAB-receptor subtypes assemble into functional heteromeric complexes
Kaupmann, K., Malitschek, B., Schuler, V., Heid, J., Froestl, W., Beck, P., Mosbacher, J., Bischoff, S., Kulik, A., Shigemoto, R., et al. (1998) · Nature · doi:10.1038/25360 · Cited by 1,195
Heterodimerization is required for the formation of a functional GABAB receptor
White, J. H., Wise, A., Main, M. J., Green, A., Fraser, N. J., Disney, G. H., Barnes, A. A., Emson, P., Foord, S. M., & Marshall, F. H. (1998) · Nature · doi:10.1038/25354 · Cited by 1,182
Differential signal transduction by five splice variants of the PACAP receptor
Spongier, D., Waeber, C., Pantaloni, C., Holsboer, F., Bockaert, J., Seeburgt, P. H., & Journot, L. (1993) · Nature · doi:10.1038/365170a0 · Cited by 1,182
GABAB receptors function as a heteromeric assembly of the subunits GABABR1 and GABABR2
Jones, K. A., Borowsky, B., Tamm, J. A., Craig, D. A., Durkin, M. M., Dai, M., Yao, W.-J., Johnson, M., Gunwaldsen, C., Huang, L.-Y., et al. (1998) · Nature · doi:10.1038/25348 · Cited by 1,079
STRUCTURE AND FUNCTION OF G PROTEIN-COUPLED RECEPTORS
Strader, C. D., Fong, T. M., Tota, M. R., Underwood, D., & Dixon, R. A. F. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.000533 · Cited by 1,079
Cited by
Nichols, D. E., & Nichols, C. D. (2008) · Chemical Reviews · doi:10.1021/cr078224o · Cited by 895
Synthetic Multivalent Ligands as Probes of Signal Transduction
Kiessling, L. L., Gestwicki, J. E., & Strong, L. E. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200502794 · Cited by 864
Wei, H., Ahn, S., Shenoy, S. K., Karnik, S. S., Hunyady, L., Luttrell, L. M., & Lefkowitz, R. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834556100 · Cited by 690
GRKs and β-arrestins: roles in receptor silencing, trafficking and signaling
Reiter, E., & Lefkowitz, R. J. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.03.008 · Cited by 666
Allosteric binding sites on cell-surface receptors: novel targets for drug discovery
Christopoulos, A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd746 · Cited by 664
Cannabinoid Receptors: Where They are and What They do
Mackie, K. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01671.x · Cited by 638
Seifert, R., & Wenzel-Seifert, K. (2002) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-002-0588-0 · Cited by 637
G protein coupled receptor structure and activation
Kobilka, B. K. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.10.021 · Cited by 623
High-throughput screening assays for the identification of chemical probes
Inglese, J., Johnson, R. L., Simeonov, A., Xia, M., Zheng, W., Austin, C. P., & Auld, D. S. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.17 · Cited by 614
TNF receptor subtype signalling: Differences and cellular consequences
MacEwan, D. J. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00262-5 · Cited by 610
Kenakin, T., & Miller, L. J. (2010) · Pharmacological Reviews · doi:10.1124/pr.108.000992 · Cited by 573
Self-citationMillan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Azzi, M., Charest, P. G., Angers, S., Rousseau, G., Kohout, T., Bouvier, M., & Piñeyro, G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1936664100 · Cited by 523
Therapeutic potential of β-arrestin- and G protein-biased agonists
Whalen, E. J., Rajagopal, S., & Lefkowitz, R. J. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.11.004 · Cited by 510
Endogenous and Exogenous Opioids in Pain
Corder, G., Castro, D. C., Bruchas, M. R., & Scherrer, G. (2018) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-080317-061522 · Cited by 502
Gesty-Palmer, D., Chen, M., Reiter, E., Ahn, S., Nelson, C. D., Wang, S., Eckhardt, A. E., Cowan, C. L., Spurney, R. F., Luttrell, L. M., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513380200 · Cited by 476
Principles: Receptor theory in pharmacology
Kenakin, T. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.02.012 · Cited by 412
Self-citationMOLECULAR MECHANISM OF 7TM RECEPTOR ACTIVATION—A GLOBAL TOGGLE SWITCH MODEL
Schwartz, T. W., Frimurer, T. M., Holst, B., Rosenkilde, M. M., & Elling, C. E. (2006) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141218 · Cited by 408
Ostrom, R. S., & Insel, P. A. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705930 · Cited by 398
Regulation of Adiposity and Obesity Risk By Dietary Calcium: Mechanisms and Implications
Zemel, M. B. (2002) · Journal of the American College of Nutrition · doi:10.1080/07315724.2002.10719212 · Cited by 389
Melanocortin‐1 receptor structure and functional regulation
García‐Borrón, J. C., Sánchez‐Laorden, B. L., & Jiménez‐Cervantes, C. (2005) · Pigment Cell Research · doi:10.1111/j.1600-0749.2005.00278.x · Cited by 385
Y. Maximov, P., M. Lee, T., & Craig Jordan, V. (2013) · Current Clinical Pharmacology · doi:10.2174/1574884711308020006 · Cited by 376
Dairy augmentation of total and central fat loss in obese subjects
Zemel, M. B., Richards, J., Mathis, S., Milstead, A., Gebhardt, L., & Silva, E. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802880 · Cited by 356
Sequential Binding of Agonists to the β2 Adrenoceptor
Swaminath, G., Xiang, Y., Lee, T. W., Steenhuis, J., Parnot, C., & Kobilka, B. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310888200 · Cited by 333
Hermans, E. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00051-2 · Cited by 327
How chemokines invite leukocytes to dance
Thelen, M., & Stein, J. V. (2008) · Nature Immunology · doi:10.1038/ni.f.207 · Cited by 324
Ligand-selective receptor conformations revisited: the promise and the problem
Kenakin, T. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00167-6 · Cited by 321
Self-citationDrug Efficacy at G Protein–Coupled Receptors
Kenakin, T. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.091401.113012 · Cited by 316
Self-citationDe Deurwaerdère, P., Navailles, S., Berg, K. A., Clarke, W. P., & Spampinato, U. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0112-04.2004 · Cited by 306
Karnik, S. S., Unal, H., Kemp, J. R., Tirupula, K. C., Eguchi, S., Vanderheyden, P. M. L., & Thomas, W. G. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.010454 · Cited by 302
Beene, D. L., Brandt, G. S., Zhong, W., Zacharias, N. M., Lester, H. A., & Dougherty, D. A. (2002) · Biochemistry · doi:10.1021/bi020266d · Cited by 300
Biased Receptor Signaling in Drug Discovery
Kenakin, T. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.016790 · Cited by 294
Self-citationGalandrin, S., & Bouvier, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026716 · Cited by 291
The Role of Dairy Foods in Weight Management
Zemel, M. B. (2005) · Journal of the American College of Nutrition · doi:10.1080/07315724.2005.10719502 · Cited by 272
Functional Selectivity through Protean and Biased Agonism: Who Steers the Ship?
Kenakin, T. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.040352 · Cited by 270
Self-citationJacobsen, R., Lorenzen, J. K., Toubro, S., Krog-Mikkelsen, I., & Astrup, A. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802785 · Cited by 264
Efficacy at g-protein-coupled receptors
Kenakin, T. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd722 · Cited by 263
Self-citationConstitutive μ-Opioid Receptor Activity Leads to Long-Term Endogenous Analgesia and Dependence
Corder, G., Doolen, S., Donahue, R. R., Winter, M. K., Jutras, B. L., He, Y., Hu, X., Wieskopf, J. S., Mogil, J. S., Storm, D. R., et al. (2013) · Science · doi:10.1126/science.1239403 · Cited by 240
Activation and Inhibition of Adenylyl Cyclase Isoforms by Forskolin Analogs
Pinto, C., Papa, D., Hübner, M., Mou, T.-C., Lushington, G. H., & Seifert, R. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.131904 · Cited by 82
Rodrigues, R. S., Moreira, J. B., Mateus, J. M., Barateiro, A., Paulo, S. L., Vaz, S. H., Lourenço, D. M., Ribeiro, F. F., Soares, R., Loureiro-Campos, E., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02877-0 · Cited by 12
Metadata
- Authors
- KENAKIN, T.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2001-03
- Volume
- 15
- Issue
- 3
- Pages
- 598-611
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2087135060
- Cited by
- 408
- References
- 100
- FWCI
- 8.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.